Open Insider Trading Activity for Onkure Therapeutics, Inc. President and CEO Saccomano Nicholas A
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting OKUR | 2026-09-23 | 2026-09-21 | Onkure Therapeutics, Inc. | Saccomano Nicholas A | President and CEO | Sell | 1 | 87 | $2.97 | $258.76 | 0.77% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting OKUR | 2026-03-24 | 2026-03-23 | Onkure Therapeutics, Inc. | Saccomano Nicholas A | President and CEO | Sell | 1 | 86 | $4.16 | $357.76 | 1.16% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting OKUR | 2025-12-23 | 2025-12-22 | Onkure Therapeutics, Inc. | Saccomano Nicholas A | President and CEO | Sell | 1 | 87 | $2.97 | $258.39 | 1.16% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting OKUR | 2025-09-24 | 2025-09-22 | Onkure Therapeutics, Inc. | Saccomano Nicholas A | President and CEO | Sell | 1 | 88 | $2.62 | $230.56 | 2.45% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting OKUR | 2025-06-25 | 2025-06-23 | Onkure Therapeutics, Inc. | Saccomano Nicholas A | President and CEO | Sell | 1 | 88 | $2.38 | $209.44 | 2.39% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting OKUR | 2025-04-08 | 2025-04-07 | Onkure Therapeutics, Inc. | Saccomano Nicholas A | President and CEO | Sell | 2 | 874 | $2.94 | $2,569.86 | 9.98% | View Filing |